Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China

Introduction: The treatment of acute myocardial infarction (AMI) during the COVID-19 pandemic has been affected to varying degrees. This study is the first to explore the impact of COVID-19 on the treatment and prognosis of rural and urban AMI in developing countries. Methodology: A total of 128...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Chen, Min Zhang, Yiwen Wang, Zhi Li, Yu Yang, Zhirong Wang, Yuan Lu
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2022-09-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/16747
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850193200250093568
author Lei Chen
Min Zhang
Yiwen Wang
Zhi Li
Yu Yang
Zhirong Wang
Yuan Lu
author_facet Lei Chen
Min Zhang
Yiwen Wang
Zhi Li
Yu Yang
Zhirong Wang
Yuan Lu
author_sort Lei Chen
collection DOAJ
description Introduction: The treatment of acute myocardial infarction (AMI) during the COVID-19 pandemic has been affected to varying degrees. This study is the first to explore the impact of COVID-19 on the treatment and prognosis of rural and urban AMI in developing countries. Methodology: A total of 128 patients with AMI in our hospital during the COVID-19 pandemic were enrolled. A total of 197 patients diagnosed with AMI before the COVID-19 pandemic were selected as the control group and one year of follow-up was performed. Results: Hospital stay and the proportion of Killip class ≥ 2 patients were increased among rural AMI patients in the ‘during COVID-19’ group, compared with the ‘before COVID-19’ group. Among ST-segment elevation myocardial infarction (STEMI) total and rural STEMI patients, the treatment time in the during-COVID-19 group was longer than that in the before-COVID-19 group, whereas only the symptom to door (S to D) total and door to balloon (D to B) were extended in urban STEMI patients. In AMI total and rural AMI patients, major adverse cardiovascular events (MACEs) and all-cause mortality were increased in the during-COVID-19 group compared with the before-COVID-19 group. Kaplan–Meier analysis revealed that the survival and occurrence of MACEs in AMI total and rural AMI patients were significantly higher in the during-COVID-19 group. Conclusions: The COVID-19 pandemic led to delayed treatment and worse prognosis in AMI patients. Rural areas appear to be at a greater risk.
format Article
id doaj-art-35fbce176a054f01b813de045719416a
institution OA Journals
issn 1972-2680
language English
publishDate 2022-09-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-35fbce176a054f01b813de045719416a2025-08-20T02:14:20ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802022-09-01160910.3855/jidc.16747Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, ChinaLei Chen0Min Zhang1Yiwen Wang2Zhi Li3Yu Yang4Zhirong Wang5Yuan Lu6Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China Introduction: The treatment of acute myocardial infarction (AMI) during the COVID-19 pandemic has been affected to varying degrees. This study is the first to explore the impact of COVID-19 on the treatment and prognosis of rural and urban AMI in developing countries. Methodology: A total of 128 patients with AMI in our hospital during the COVID-19 pandemic were enrolled. A total of 197 patients diagnosed with AMI before the COVID-19 pandemic were selected as the control group and one year of follow-up was performed. Results: Hospital stay and the proportion of Killip class ≥ 2 patients were increased among rural AMI patients in the ‘during COVID-19’ group, compared with the ‘before COVID-19’ group. Among ST-segment elevation myocardial infarction (STEMI) total and rural STEMI patients, the treatment time in the during-COVID-19 group was longer than that in the before-COVID-19 group, whereas only the symptom to door (S to D) total and door to balloon (D to B) were extended in urban STEMI patients. In AMI total and rural AMI patients, major adverse cardiovascular events (MACEs) and all-cause mortality were increased in the during-COVID-19 group compared with the before-COVID-19 group. Kaplan–Meier analysis revealed that the survival and occurrence of MACEs in AMI total and rural AMI patients were significantly higher in the during-COVID-19 group. Conclusions: The COVID-19 pandemic led to delayed treatment and worse prognosis in AMI patients. Rural areas appear to be at a greater risk. https://jidc.org/index.php/journal/article/view/16747COVID-19acute myocardial infarctionurban areasrural areasMACEs
spellingShingle Lei Chen
Min Zhang
Yiwen Wang
Zhi Li
Yu Yang
Zhirong Wang
Yuan Lu
Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
Journal of Infection in Developing Countries
COVID-19
acute myocardial infarction
urban areas
rural areas
MACEs
title Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
title_full Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
title_fullStr Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
title_full_unstemmed Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
title_short Impact of the COVID-19 pandemic on the treatment and prognosis of acute myocardial infarction in Xuzhou, China
title_sort impact of the covid 19 pandemic on the treatment and prognosis of acute myocardial infarction in xuzhou china
topic COVID-19
acute myocardial infarction
urban areas
rural areas
MACEs
url https://jidc.org/index.php/journal/article/view/16747
work_keys_str_mv AT leichen impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT minzhang impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT yiwenwang impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT zhili impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT yuyang impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT zhirongwang impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina
AT yuanlu impactofthecovid19pandemiconthetreatmentandprognosisofacutemyocardialinfarctioninxuzhouchina